MetaCap

Cryo-Cell International (CCEL) vs NewGenIvf Group (NIVF)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cryo-Cell International is the larger company by market cap ($33.5 million vs $80,770), about 414.3 times the size. On valuation, NewGenIvf Group trades at a lower forward P/E (0.0x vs 207.5x for Cryo-Cell International). NewGenIvf Group converts more of its revenue into profit, with a net margin of 209.0% versus -7.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CCEL+6.14%NIVF-74.62%
+1345%+601%-142%
Oct 7, 20261 yearNov 20, 2026
CCEL-4.82%NIVF-62.69%
+2024%+931%-162%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CCEL versus NIVF key metrics
MetricCCELNIVF
Share price$4.15$0.0269
Market cap$33.46M$80.77K
1-day change0.00%-23.14%
YTD return+20.64%—
1-year return+1.47%—
5-year return-66.34%—
Forward P/E207.500.00
EPS (TTM)$-0.24$-34,064.71
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$31.57M$4.73M
Revenue growth (YoY)-1.31%-13.01%
Net income (latest FY)$-2.43M$9.88M
Gross margin76.63%20.22%
Operating margin1.53%-226.95%
Net margin-7.70%209.02%
52-week high$5.45$7,257.60
52-week low$2.72$0.0229
Distance from 52-week high-23.85%-100.00%
Analyst consensus—none
Avg. price target upside—+472316.36%
Average volume13.02K6.57M
Shares outstanding8.06M2.99M
Employees7287
SectorHealth CareHealth Care
IndustryMisc Health and Biotechnology ServicesMisc Health and Biotechnology Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Cryo-Cell International is about 414.3 times larger than NewGenIvf Group by market value ($33.46M vs $80.77K).
  • NewGenIvf Group is more profitable, keeping 209.0 cents of every revenue dollar as net income versus -7.7 cents for Cryo-Cell International.
  • Cryo-Cell International grew revenue faster in its latest fiscal year (-1.31% vs -13.01%).

About Cryo-Cell International

CCEL stock →

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States.

Health Care · Misc Health and Biotechnology Services · 72 employees

About NewGenIvf Group

NIVF stock →

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing.

Health Care · Misc Health and Biotechnology Services · 87 employees

CCEL vs NIVF FAQ

Which is bigger, Cryo-Cell International or NewGenIvf Group?

Cryo-Cell International (CCEL) is larger, with a market capitalization of $33.46M compared with $80.77K for NewGenIvf Group (NIVF).

Are Cryo-Cell International and NewGenIvf Group in the same industry?

Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.

More comparisons